The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ataxia (SCA).

And if migraines happen regularly, they can seriously disrupt your life. The good news? There are simple, proactive steps you ...